GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bionime Corp (TPE:4737) » Definitions » Net Income From Continuing Operations

Bionime (TPE:4737) Net Income From Continuing Operations : NT$-188 Mil (TTM As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Bionime Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Bionime's net income from continuing operations for the three months ended in Mar. 2025 was NT$-15 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-188 Mil.

Bionime Net Income From Continuing Operations Historical Data

The historical data trend for Bionime's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionime Net Income From Continuing Operations Chart

Bionime Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.11 74.59 86.48 -31.88 -185.71

Bionime Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.10 -53.05 -71.59 -47.98 -15.22

Bionime Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-188 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionime Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bionime Corp (TPE:4737) » Definitions » Net Income From Continuing Operations
Comparable Companies
TPE:1783 TPE:1752 ROCO:6612 ROCO:6527 ROCO:4126 ROCO:4116 ROCO:4111 TPE:1786 ROCO:6543 ROCO:6730 ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN
Traded in Other Exchanges
N/A
Address
No. 100, Daqing Street, Section 2, South District, Taichung, TWN, 40242
Website
https://www.bionime.com
Bionime Corp is engaged in the manufacturing and selling of medical instruments, providing biotechnology services, examining pharmaceuticals, and selling precision instruments. The company's products include blood glucose monitoring devices, Lancing devices, Testing Strips, and blood glucose testing chips which are applied in the testing and monitoring of blood glucose density.

Bionime Headlines

No Headlines